George Hill Analyst PerformanceManaging Director, Equity Research Analyst at Deutsche Bank AktiengesellschaftGeorge Hill is a stock analyst at Deutsche Bank Aktiengesellschaft focused in the medical sector, covering 20 publicly traded companies. Over the past year, George Hill has issued 17 stock ratings, including buy and hold recommendations. While full access to George Hill's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights George Hill's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings107 Last 11 YearsBuy Recommendations56.31% 58 Buy RatingsCompanies Covered20 Unique Companies Ratings Distribution103RatingsDistribution of strong buy, buy, hold, and sell ratings by George Hill.RatingPercentageCount Strong Buy0.0%0 ratings Buy56.3%58 ratings Hold42.7%44 ratings Sell1.0%0 ratingsOut of 103 total stock ratings issued by George Hill at Deutsche Bank Aktiengesellschaft, the majority (56.3%) have been Buy recommendations, followed by 42.7% Hold and 1.0% Sell.Best & Worst CallsBest Call000.0%EHTHApr 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%EHTHFeb 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE65.0% of companies on NYSE13 companiesNASDAQ30.0% of companies on NASDAQ6 companiesOTCMKTS5.0% of companies on OTCMKTS1 companyGeorge Hill, an analyst at Deutsche Bank Aktiengesellschaft, currently covers 20 companies listed on NYSE, NASDAQ and OTCMKTS, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical15 companies75.0%Computer and Technology1 company5.0%Retail/Wholesale1 company5.0%Business Services1 company5.0%Finance1 company5.0%Miscellaneous1 company5.0%George Hill of Deutsche Bank Aktiengesellschaft specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Retail/Wholesale companies.Coverage IndustriesIndustryPercentageMEDICAL SERVICES8 companies40.0%MED - HMO3 companies15.0%MED/DENTAL - SUPP2 companies10.0%INTERNET SOFTWARE1 company5.0%MEDICAL INFO SYS1 company5.0%RETAIL - DRUG STR1 company5.0%COMPUTER INTEGRATED SYSTEMS DESIGN1 company5.0%INS - BROKERS1 company5.0%MED INSTRUMENTS1 company5.0%HOLDING & OTHER INVESTMENT OFFICES1 company5.0% About George HillGeorge Hill joined Deutsche Bank as a Managing Director and equity research analyst covering the Healthcare Technology & Service sector in April 2019. He's been covering the healthcare technology and pharmaceutical services space for over 20 years. Mr. Hill frequently appears in the media, as a regular speaker at industry events, and lectured at the Wharton School on healthcare technology topics. He was Managing Director and senior equity research analyst at RBC Capital Markets, covering the drug supply chain and healthcare technology industries. Prior to RBC, he held similar positions at Deutsche Bank, Citigroup and SVB Leerink. He spent time as the senior calling officer for Leerink's healthcare services investment banking group. Mr. Hill started his career in investment research as an investment associate at Citigroup Asset Management. Before that, he was a journalist covering the pharmaceutical marketing and services space. Mr. Hill holds a bachelor's degree from Rutgers University.Follow on LinkedIn George Hill's Ratings History at Deutsche Bank Aktiengesellschaft Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAGLAgilon Health5/7/2026Upgrade$27.81$49.00Buy$0.0000.00% ROIAGLAgilon Health4/9/2026Set Price Target$20.39$33.00Hold$0.0000.00% ROIHQYHealthEquity3/19/2026Boost Price Target$81.60$128.00Buy$0.0000.00% ROIWAYWaystar3/12/2026Lower Price Target$24.50$37.00Buy$0.0000.00% ROIHIMSHims & Hers Health3/10/2026Boost Price Target$22.12$28.00Hold$0.0000.00% ROITDOCTeladoc Health3/10/2026Upgrade$5.31$11.00Buy$0.0000.00% ROIHUMHumana2/13/2026Set Price Target$181.41$180.00Hold$0.0000.00% ROIHIMSHims & Hers Health2/10/2026Set Price Target$18.31$31.00Hold$0.0000.00% ROICICigna Group2/10/2026Boost Price Target$293.06$304.00Buy$0.0000.00% ROIELVElevance Health1/29/2026Reiterated Rating$344.46$332.00Hold$0.0000.00% ROIELVElevance Health12/19/2025Reiterated Rating$344.81$320.00Hold$0.0000.00% ROIMCKMcKesson12/10/2025Reiterated Rating$800.73Buy$0.0000.00% ROICICigna Group11/3/2025Lower Price Target$264.54$301.00Buy$0.0000.00% ROIMCKMcKesson9/24/2025Boost Price Target$739.48$856.00Buy$0.0000.00% ROIGDRXGoodRx8/11/2025Reiterated Rating$3.47$6.00Hold$0.0000.00% ROICICigna Group8/5/2025Set Price Target$271.17$415.00Buy$0.0000.00% ROIHQYHealthEquity6/5/2025Boost Price Target$114.87$115.00Buy$0.0000.00% ROIUNHUnitedHealth Group5/14/2025Lower Price Target$311.69$362.00Buy$000.0000.00% ROIWBAWalgreens Boots Alliance2/28/2025Downgrade$11.23$9.00Sell$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenWeiss RatingsUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
